Prostate cancer trials in Switzerland

In Switzerland 43 Also abroad 1480

43 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Switzerland
Erectile Function PRESERVation in Definitive Radiotherapy for Prostate Cancer by MRI-Enhanced Adaptive Sparing of the Neurovascular Bundle
Where
Zurich
Age
18 years and over
People
48
Run by
University of Zurich
See details and how to joinNCT07916779
No phaseTaking people
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
Where
Lausanne
Age
18 years and over
People
74
Run by
University of Lausanne Hospitals
See details and how to joinNCT06482489
Phase 3Taking people
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Where
Aarau, Basel, Fribourg, Geneva, Zurich
Age
18 years and over
People
1,440 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00
No phaseTaking people
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
Where
Basel
People
753
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07484269
Phase 2Taking people
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Where
Baden, Basel, Bellinzona, Chur, Frauenfeld, Geneva, Lucerne, Rapperswil, Sankt Gallen, Winterthur, Zurich
Age
18 years and over
People
42
Run by
Swiss Cancer Institute
See details and how to joinNCT07365423
Phase 3Taking people
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Where
Aarau
Age
18 years and over
People
1,500 worldwide
Run by
NRG Oncology
See details and how to joinNCT05946213
Phase 3Taking people
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Where
Geneva, Lucerne, Zurich
Age
18 years to 100 years
People
450 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00
Phase 3Taking people
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Where
Bern, Lausanne, Sankt Gallen, Zurich
Age
18 years and over
People
750 worldwide
Run by
Amgen
See details and how to joinNCT07213674
No phaseTaking people
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Where
Many Locations
Age
18 years and over
People
1,600 worldwide
Run by
Bayer
See details and how to joinNCT07344779
Phase 3Taking people
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Where
Bern, Geneva, Zurich
Age
18 years and over
People
670 worldwide
Run by
AstraZeneca
See details and how to joinNCT07611110
Phase 3Taking people
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Where
Aarau, Chur
Age
18 years and over
People
1,330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00
Phase 3Taking people
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Where
Bern
Age
18 years and over
People
1,000 worldwide
Run by
Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00
Phase 2Taking people
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Where
Aarau, Baden, Bellinzona, Bern, Chur, Geneva, Lausanne, Lucerne, Sankt Gallen, Winterthur, Zurich
Age
18 years and over
People
162
Run by
Swiss Cancer Institute
See details and how to joinNCT06401980
Phase 3Taking people
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Where
Aarau
Age
18 years and over
People
1,273 worldwide
Run by
SWOG Cancer Research Network
See details and how to joinNCT03678025
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Chur, Sankt Gallen, Winterthur
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
No phaseTaking people
Tractography-Guided Nerve-Sparing in Prostate Cancer
Where
Geneva
Age
18 years and over
People
23
Run by
Massimo Valerio
See details and how to joinNCT07847385
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Basel, Bellinzona, Sankt Gallen
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 2/3Taking people
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Where
Basel, Bellinzona, Bern
Age
18 years to 100 years
People
443 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00
No phaseTaking people
SPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer
Where
Geneva
Age
18 years and over
People
26
Run by
Massimo Valerio
See details and how to joinNCT07826858
Phase 1/2Taking people
Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
Where
Bellinzona
Age
18 years and over
People
78 worldwide
Run by
Institute of Cancer Research, United Kingdom
See details and how to joinNCT07002320
Phase 3Not yet taking people in Switzerland
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
Where
Aarau, Bellinzona, Bern, Chur, Münsterlingen, Winterthur, Zurich
Age
18 years and over
People
140 worldwide
Run by
Ente Ospedaliero Cantonale, Bellinzona
See details and how to joinNCT07782112
Phase 1Taking people
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Where
Bellinzona, Chur, Lausanne, Sankt Gallen
Age
18 years and over
People
479 worldwide
Run by
Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00
No phaseNot yet taking people in Switzerland
Weekly Online CT or MR Adaptive Definitive SBRT for Regionally Metastatic Prostate Cancer
Where
Zurich
Age
18 years and over
People
54 worldwide
Run by
University of Zurich
See details and how to joinNCT07591051
No phaseTaking people
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)
Where
Basel
Age
50 years and over
People
300
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT07762911
Phase 1/2Not yet taking people in Switzerland
FAPI PET Imaging - An Exploratory Study
Where
Baden, Geneva, Genolier, Lucerne, Zurich
Age
18 years and over
People
770
Run by
Martin Huellner
See details and how to joinNCT07705074